US Patent Issued to Sanofi on Oct. 28 for "Antigenic multimeric respiratory syncytial virus polypeptides" (New Jersey Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,454,553, issued on Oct. 28, was assigned to Sanofi (Paris).

"Antigenic multimeric respiratory syncytial virus polypeptides" was invented by Kurt Swanson (Bridgewater, N.J.), Chih-Jen Wei (Bridgewater, N.J.) and Gary J. Nabel (Bridgewater, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure relates to antigenic multimeric respiratory syncytial virus (RSV) G polypeptides for use in eliciting an immune response to RSV."

The patent was filed on Sept. 29, 2021, under Application No. 17/489,249.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u...